+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Bropirimine (CAS 56741-95-8) Global Market Research Report 2024

  • PDF Icon

    Report

  • 50 Pages
  • April 2024
  • Region: Global
  • Merchant Research and Consulting Ltd
  • ID: 4168036
Description Jump to:
This global report is a result of industry experts’ diligent work on researching the world market of Bropirimine. The report helps to build up a clear view of the market trends and developments, identify major players in the industry, and estimate main downstream sectors.

The Bropirimine global market report's key points:

  • Bropirimine description, applications and related patterns
  • Bropirimine market situation
  • Bropirimine manufacturers and distributors
  • Bropirimine prices
  • Bropirimine end-users
  • Bropirimine downstream industries trends
The first chapter introduces the product (composition, structure, hazards, storage, toxicological & ecological information, etc.).

The second chapter focuses on Bropirimine end-uses. The third chapter summarizes data about manufacturing methods.

The fourth chapter is about the related patents. The fifth chapter deals with Bropirimine market trends and forecast, distinguish Bropirimine manufacturers and suppliers.

The sixth chapter provides Bropirimine prices data.

The seventh chapter analyses Bropirimine downstream markets.


This product will be delivered within 5-7 business days.

Table of Contents

1. BROPIRIMINE GENERAL INFORMATION
1.1. General information, synonyms
1.2. Composition, chemical structure
1.3. Safety information
1.4. Hazards identification
1.5. Handling and storage
1.6. Toxicological & ecological information
1.7. Transport information
2. BROPIRIMINE APPLICATIONS3. BROPIRIMINE MANUFACTURING METHODS4. BROPIRIMINE PATENTS
5. BROPIRIMINE MARKET WORLDWIDE
5.1. Global Bropirimine market analysis: market constraints, drivers and opportunities
5.2. Manufacturers of Bropirimine
  • Europe
  • Asia
  • North America
  • Etc.
5.3. Suppliers of Bropirimine
  • Europe
  • Asia
  • North America
  • Etc.
5.4. Market forecast
6. BROPIRIMINE MARKET PRICES
  • Europe
  • Asia
  • North America
7. BROPIRIMINE END-USE SECTOR

Related Topics

Related Reports

Demecolcine (CAS 477-30-5) Global Market Research Report 2024 - Product Image

Demecolcine (CAS 477-30-5) Global Market Research Report 2024

  • Report
  • 50 Pages
  • Global
From
Decitabine (CAS 2353-33-5) Global Market Research Report 2024 - Product Image

Decitabine (CAS 2353-33-5) Global Market Research Report 2024

  • Report
  • 50 Pages
  • Global
From
Paraneoplastic Syndrome Treatment Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Paraneoplastic Syndrome Treatment Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 96 Pages
  • Global
From
Lysosomal Alpha Glucosidase Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Image

Lysosomal Alpha Glucosidase Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • 91 Pages
  • Global
From
ADC Technology Market: Focus on ADC Linker and ADC Conjugation Technologies (2nd Edition) - Distribution by Generation of ADC Technology, Type of Conjugation, Type of Linker and Key Geographical Regions: Industry Trends and Global Forecasts, 2023-2035 - Product Image

ADC Technology Market: Focus on ADC Linker and ADC Conjugation Technologies (2nd Edition) - Distribution by Generation of ADC Technology, Type of Conjugation, Type of Linker and Key Geographical Regions: Industry Trends and Global Forecasts, 2023-2035

  • Report
  • 407 Pages
  • Global
From

About the Bropirimine Market

Bropirimine is an oncology drug used to treat certain types of cancer. It is a small molecule inhibitor of the enzyme dihydroorotate dehydrogenase (DHODH), which is involved in the production of pyrimidine nucleotides. Bropirimine has been approved by the US Food and Drug Administration (FDA) for the treatment of advanced renal cell carcinoma (RCC) and advanced hepatocellular carcinoma (HCC). It is also being investigated for the treatment of other types of cancer, including non-small cell lung cancer (NSCLC), colorectal cancer (CRC), and melanoma. Bropirimine is available in both oral and intravenous formulations. It is typically used in combination with other drugs, such as immunotherapies, targeted therapies, and chemotherapy. The drug is typically administered in cycles, with each cycle lasting for a few weeks. The market for Bropirimine is growing, as it is becoming increasingly used in the treatment of various types of cancer. Companies in the market include Bristol-Myers Squibb, Merck, Pfizer, and AstraZeneca. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.